SCHEMBL7115658

SCHEMBL7115658

O=[N+]([O-])c1cc(S(=O)(=O)Nc2ccccc2)ccc1Nc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.72
TDP1 Q9NUW8 3/20 0.72
POLB P06746 1/20 0.72
LMNA P02545 6/20 0.70
MEN1 O00255 5/20 0.70
KMT2A Q03164 5/20 0.70
WNK1 Q9H4A3 1/20 0.67
L3MBTL1 Q9Y468 4/20 0.61
PKM P14618 2/20 0.60
ALDH3A1 P30838 4/20 0.59
HCAR3 P49019 1/20 0.58
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 1/20 0.58
CASP7 P55210 1/20 0.58
CA12 O43570 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
HTT P42858 2/20 0.57
TP53 P04637 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29363201 1.00 MAPT (0.72) MAPTTDP1POLBLMNAMEN1
SCHEMBL11209685 0.92 MAPT (0.67) MAPTTDP1POLBLMNAMEN1
SCHEMBL9906419 0.89 FFAR4 (0.67) MAPTTDP1POLBLMNAMEN1
SCHEMBL11515827 0.89 MAPT (0.62) MAPTTDP1POLBLMNAMEN1
SCHEMBL8029981 0.87 MAPT (0.69) MAPTTDP1POLBLMNAMEN1
SCHEMBL16188270 0.87 ALDH3A1 (0.76) MAPTTDP1POLBLMNAMEN1
SCHEMBL11694650 0.86 ALDH3A1 (0.60) MAPTTDP1POLBLMNAMEN1
SCHEMBL9487112 0.84 MAPT (1.00) MAPTTDP1POLBLMNAMEN1
SCHEMBL11044743 0.84 MAPT (0.74) MAPTTDP1POLBLMNAMEN1
SCHEMBL9817053 0.84 MAPT (0.74) MAPTTDP1POLBLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021161577-A1 FIRE RETARDANT AND SIMULTANEOUSLY DYEING METHOD FOR POLYESTER-BASED TEXTILE 大京化学株式会社 2021-08-19 WO disclosed
US-10202339-B2 Therapeutic compounds and compositions AGIOS PHARMACEUTICALS, INC. (US) 2019-02-12 US disclosed
US-10202339-B2 Therapeutic compounds and compositions AGIOS PHARMACEUTICALS, INC. (US) 2019-02-12 US disclosed
EP-2992053-B1 COLORING AGENTS NATURALISED WITH THE 6'-DEOXY-6'-(PIPERAZINYL)LACTOSE MOIETY UNIV DEGLI STUDI DI FIRENZE (IT) 2018-11-28 EP disclosed
EP-2992053-A1 COLORING AGENTS NATURALISED WITH THE 6'-DEOXY-6'-(PIPERAZINYL)LACTOSE MOIETY Universita' Degli Studi di Firenze (IT) 2016-03-09 EP disclosed
US-20150299115-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC (US) 2015-10-22 US disclosed
EP-2906212-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS Agios Pharmaceuticals, Inc. (US) 2015-08-19 EP disclosed
WO-2014177528-A1 COLORING AGENTS NATURALISED WITH THE 6'-DEOXY-6'-(PIPERAZINYL)LACTOSE MOIETY UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2014-11-06 WO disclosed
WO-2014177528-A1 COLORING AGENTS NATURALISED WITH THE 6'-DEOXY-6'-(PIPERAZINYL)LACTOSE MOIETY UNIVERSITA' DEGLI STUDI DI FIRENZE (IT) 2014-11-06 WO disclosed
WO-2014062511-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS AGIOS PHARMACEUTICALS, INC. (US) 2014-04-24 WO disclosed
EP-0124606-A4 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS. WILSON ROBERT B (US) 1985-09-18 EP disclosed
EP-0126752-A4 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES. WILSON ROBERT B (US) 1985-09-16 EP disclosed
WO-1985003959-A1 DYE COMPOSITION AND METHOD OF USE THEREOF FOR COLORING THERMOPLASTIC MATERIALS BUCHANAN WILSON ROBERT 1985-09-12 WO disclosed
EP-0126752-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES WILSON, Robert Buchanan (US) 1984-12-05 EP disclosed
EP-0124606-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS WILSON, Robert Buchanan (US) 1984-11-14 EP disclosed
WO-1984001971-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR SYNTHETIC ARTICLES WILSON ROBERT B 1984-05-24 WO disclosed
WO-1984001972-A1 WATERLESS DIP DYE COMPOSITION AND METHOD OF USE THEREOF FOR TEXTILE-RELATED MATERIALS WILSON ROBERT B 1984-05-24 WO disclosed
US-4185962-A Dyeing with organic dyestuffs dispersed in an organic liquid SANDOZ LTD. (CH) 1980-01-29 US disclosed
US-4009158-A DYEING AND PRINTING FIBERS SANDOZ LTD. (CH) 1977-02-22 US disclosed
US-3865805-A Azo compounds having a 2-nitro-4-phenylsulfamoyldiphenyl amine nucleus ALTERMATT RUEDI 1975-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202339-B2 Therapeutic compounds and compositions IDH3A, IDH1, IDH2 MAPT 4036/4885TDP1 1344/4885POLB 3561/4885
US-20150299115-A1 THERAPEUTIC COMPOUNDS AND COMPOSITIONS IDH3A, IDH1, IDH2 MAPT 4036/4885TDP1 1344/4885POLB 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.